Does glucagon-like peptide-2 regulate release of chylomicrons from the intestine?
Administration of GLP-2 to men causes the release of chylomicrons that comprise previously synthesized and stored apoB-48 and lipids. This transiently increases TRL apoB-48 levels compared with placebo. Clinical trials number at www.clinicaltrials.gov: NCT 01958775.
In this multicenter study, the use of HA was not associated with a lower risk of hemorrhagic or global complications.